Education
About Us
Working with TipRanks
Follow Us
Monopar Therapeutics Inc (MNPR)
NASDAQ:MNPR
MNPR Analyst Ratings
Strong Buy
7 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MNPR Stock 12 Month Forecast
Average Price Target
$112.71
▲(104.15% Upside)
| Highest Price Target$130.00 | Average Price Target$112.71 | Lowest Price Target$101.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
BTIG
$104
Buy
88.37%
Upside
Reiterated
02/23/26
H.C. Wainwright
$105
Buy
90.18%
Upside
Reiterated
01/30/26
Barclays
$125
Buy
126.41%
Upside
Reiterated
01/30/26
Cantor Fitzgerald
$109
Buy
97.43%
Upside
Reiterated
01/29/26
Piper Sandler
$101
Buy
82.94%
Upside
Reiterated
01/29/26
JonesTrading
$130
Buy
135.46%
Upside
Assigned
01/23/26
Morgan Stanley
$115
Buy
108.30%
Upside
Initiated
01/09/26
Oppenheimer
$115
Buy
108.30%
Upside
Reiterated
11/14/25
Raymond James
$142→$123
Buy
122.79%
Upside
Reiterated
11/14/25
Leerink Partners
$115
Buy
108.30%
Upside
Initiated
11/10/25
Lake Street
$106
Buy
91.99%
Upside
Reiterated
11/10/25
Chardan Capital
$60→$85
Buy
53.96%
Upside
Reiterated
09/25/25
Brookline Capital Markets
$52→$93
Buy
68.45%
Upside
Reiterated
09/25/25
Lucid Capital
$71
Buy
28.60%
Upside
Initiated
06/05/25
Citi
$40
Buy
-27.55%
Downside
Reiterated
03/31/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
BTIG
$104
Buy
88.37%
Upside
Reiterated
02/23/26
H.C. Wainwright
$105
Buy
90.18%
Upside
Reiterated
01/30/26
Barclays
$125
Buy
126.41%
Upside
Reiterated
01/30/26
Cantor Fitzgerald
$109
Buy
97.43%
Upside
Reiterated
01/29/26
Piper Sandler
$101
Buy
82.94%
Upside
Reiterated
01/29/26
JonesTrading
$130
Buy
135.46%
Upside
Assigned
01/23/26
Morgan Stanley
$115
Buy
108.30%
Upside
Initiated
01/09/26
Oppenheimer
$115
Buy
108.30%
Upside
Reiterated
11/14/25
Raymond James
$142→$123
Buy
122.79%
Upside
Reiterated
11/14/25
Leerink Partners
$115
Buy
108.30%
Upside
Initiated
11/10/25
Lake Street
$106
Buy
91.99%
Upside
Reiterated
11/10/25
Chardan Capital
$60→$85
Buy
53.96%
Upside
Reiterated
09/25/25
Brookline Capital Markets
$52→$93
Buy
68.45%
Upside
Reiterated
09/25/25
Lucid Capital
$71
Buy
28.60%
Upside
Initiated
06/05/25
Citi
$40
Buy
-27.55%
Downside
Reiterated
03/31/25
Best Analysts Covering Monopar Therapeutics Inc
3 Months
xxx
Success Rate
3/6 ratings generated profit
Average Return
+51.87%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +51.87% per trade.
1 Year
Success Rate
3/6 ratings generated profit
Average Return
+19.87%
reiterated a buy rating 2 months ago
Copying Biren Amin's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +19.87% per trade.
2 Years
xxx
Success Rate
4/4 ratings generated profit
Average Return
+124.10%
initiated a xxx
rating 10 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +124.10% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MNPR Analyst Recommendation Trends
Rating
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Strong Buy
6
6
3
13
12
Buy
16
25
16
11
1
Hold
0
0
1
11
12
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
22
31
20
35
25
Each month's total comprises the sum of three months' worth of ratings.
MNPR Financial Forecast
MNPR Stock Forecast FAQ
What is MNPR’s average 12-month price target, according to analysts?
Based on analyst ratings, Monopar Therapeutics Inc’s 12-month average price target is 112.71.
What is MNPR’s upside potential, based on the analysts’ average price target?
Monopar Therapeutics Inc has 104.15% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is MNPR a Buy, Sell or Hold?
Monopar Therapeutics Inc has a consensus rating of Strong Buy which is based on 7 buy ratings, 0 hold ratings and 0 sell ratings.
What is Monopar Therapeutics Inc’s price target?
The average price target for Monopar Therapeutics Inc is 112.71. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $130.00 ,the lowest forecast is $101.00. The average price target represents 104.15% Increase from the current price of $55.21.
The highest analyst price target is $130.00 ,the lowest forecast is $101.00. The average price target represents 104.15% Increase from the current price of $55.21.
What do analysts say about Monopar Therapeutics Inc?
Monopar Therapeutics Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
How can I buy shares of MNPR?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.